Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Ruth Ca?amar
Research Specialist, Principal
Cancer Center Division
Full Page
Overview
Research
More
Collaboration
(5)
Linda Garland
Mutual work: 5 Proposals﹒3 Grants
Collaboration Details
Gregory Woodhead
Mutual work: 1 Proposal﹒1 Grant
Collaboration Details
Lizeth Evangelista
Mutual work: 13 Proposals﹒10 Grants
Collaboration Details
Shamar Young
Mutual work: 1 Grant﹒1 Proposal
Collaboration Details
Alaina Krone
Mutual work: 1 Supervisor
Collaboration Details
Grants
(13)
A Dose-Escalation and Expansion Study of the Safety and Pharmacokinetics of XB002 As Single-Agent And Combination Therapy In Subjects With Inoperable Locally Advanced or Metastatic Solid Tumors
Active
·
2024
·
$0 / $1.6M
·
External
cancer,
pharmacokinetics,
drug therapy,
clinical trial,
tumor treatment
A Phase 1b/2 Open-Label Study of Disitamab Vedotin Monotherapy or in Combination with Other Anti-Cancer Therapies in Solid Tumors
Active
·
2024
·
$0 / $724K
·
External
cancer,
immunotherapy,
clinical trial,
monotherapy,
combination therapy
A Phase 1 Study With ABBV-CLS-484 Alone And In Combination In Subjects With Locally Advanced or Metastatic Tumors
Active
·
2024
·
$0 / $635K
·
External
oncology,
clinical trial,
cancer treatment,
drug development,
immunotherapy
A First-in-human, Multicenter, Open-label, Dose Escalation and Dose Expansion Phase 1 Study in Patients with Advanced Solid Tumors to Evaluate the Safety of Intravenously Administered ALG.APV-527
Active
·
2024
·
$0 / $348.6K
·
External
oncology,
clinical trials,
immunotherapy,
pharmacology,
drug safety
Phase 1 Study of Intratumoral Administration of VAX014 in Subjects with Advanced Solid Tumors
Active
·
2023
·
$0 / $352.4K
·
External
cancer immunotherapy,
clinical trial,
tumor microenvironment,
intratumoral therapy,
solid tumors
Page 1 of 3
Previous page
Next page
